Skip to content

Released Jul 28, 2021, after the close

10-Q filed Jul 29, 2021, 29 days after period end · 0001653477-21-000053

Q2 2021 · 10-Q
Revenue$358.40M+32.4% vs Q2 2020+11.9% vs Q1 2021
Net Income$44.30M+119.3% vs Q2 2020−9.0% vs Q1 2021
EPS Diluted$1.10+124.5% vs Q2 2020−8.3% vs Q1 2021
Gross Profit$139,800,000+66.6%
Operating Income$117,700,000+75.1%
Operating Cash Flowderived$65,800,000+34.6%
Free Cash Flowderived$41,900,000+23.6%
Margins · derived
Gross margin39.0%+8.0 pt vs Q2 2020
Operating margin32.8%+8.0 pt vs Q2 2020
Net margin12.4%+4.9 pt vs Q2 2020

What the release said

The release

Same quarter

MetricQ2 2021Q2 2020Q2 2019Q2 2018
Revenue$358.40M$270.60M$352.80M$308.60M
Net Income$44.30M$20.20M$56.80M$46.70M
EPS Diluted$1.10$0.49$1.34$1.10

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR